Press Release: Nirsevimab delivers 83% reduction in RSV infant hospitalizations in a real-world clinical trial setting

Nitesh sinha May 12, 2023

https://ift.tt/ytZxCPX

Nirsevimab delivers 83% reduction in RSV infant hospitalizations in a real-world clinical trial setting

from Sanofi - Aventis Groupe https://ift.tt/2DNjEa1
via IFTTT

health care